Anne R. Bass, MD
Dr. Anne R. Bass specializes in the treatment of rheumatoid arthritis, vasculitis, Lyme disease, systemic lupus erythematosus and inflammatory eye disease. She is the director of the HSS rheumatology fellowship program and an Associate Professor of Clinical Medicine. Her research focus is on thrombotic and cardiovascular complications of orthopedic surgery, and she is chairman of the HSS venous thromboembolism prevention committee.
Back in the Game Patient Stories
Appointments
Attending Physician, Hospital for Special Surgery
Program Director Rheumatology Fellowship Program, Hospital for Special Surgery
Associate Professor of Clinical Medicine, Weill Cornell Medical College
Specialty
Specialized Centers
Special Expertise
Cancer Immunotherapy
Vasculitis
Rheumatoid Arthritis
Psoriatic Arthritis
Venous Thromboembolism
Inflammatory Eye Disease
Awards
Castle Connolly Top Regional Doctor, 2014-2018
New York Magazine Top Doctors, 2014-2018
Castle Connolly Top Doctors in New York Metro Area, 2015-2018
Languages
English
Insurance Information
Aetna
Cigna
Medicare
Oxford
Oxford Medicare
United Healthcare
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may still have coverage subject to the availability of 'out-of-network' benefits.
Book an Appointment
Dr. Bass accepts the following insurance plans:
Aetna
Cigna
Medicare
Oxford
Oxford Medicare
United Healthcare
Please note, if your insurance is not on this list, you may still have coverage subject to the availability of out-of-network benefits.
If you do not wish to go out-of-network, our Physician Referral Service will help you find an appropriate doctor.
Patient ratings for Dr. Bass
Education
Residency
Fellowship
Certification
Internal Medicine, 1988
Rheumatology, 1992, 2002
State Licensure
New York
Patient Education by Dr. Bass on HSS.edu
- Avoiding Blood Clotting Complications When Flying Long Distances Before Surgery
- Lyme Disease - Prevention and Treatment
Selected Books/Chapters
Bass AR. "Medical Considerations for Sports and Exercise Participation in the Older Athlete" in Sports Medicine: A Comprehensive Approach (2nd edition). Scuderi G, McCann,PD, eds. Elsevier Mosby, Philadelphia 2005.
Bass AR, Magid S. “Lyme Disease” in Hospital for Special Surgery Manual of Rheumatology and Outpatient Orthopedic Disorders (5th edition). Paget SA, Gibofsky A, Beary JF III, eds. Lippincott Williams & Wilkins, Philadelphia 2006.
Ashany D, Bass AR, Elkon K. “Rheumatology Laboratory Testing” in Hospital for Special Surgery Manual of Rheumatology and Outpatient Orthopedic Disorders (5th edition). Paget SA, Gibofsky A, Beary JF III, eds. Lippincott Williams & Wilkins, Philadelphia 2006.
Selected Publications
Papers:
Rogozinski L, Bass AR, Glickman I, Talle MA, Goldstein G, Wang J, Chess L, Thomas Y. The T4 Surface Antigen is Involved in the Induction of Helper Function. J. Immunology 1984; 132(2): 735-739.
Asnis PD, Gardner MJ, Leitzes AH, Ranawat A, Tuthill RP, Magid S, Peterson GE, Bass AR. The Effectiveness of Warfarin Dosing from a Nomogram Compared to House Staff Dosing. J.Arthroplasty 2007; 22(2): 213-218.
Bass AR. In Reply to Letter to the Editor. J Arthroplasty 2007; 22(6): 943-4.
Kolasinski SL, Bass AR, Kane-Wanger GF, Libman BS, Sandorfi N, Utset T. Subspecialty Choice: Why Did You Become a Rheumatologist? Arthritis Rheum 2007; 57:1546-1551.
Bass AR, Mattern CJ, Voos JE, Peterson MGE, Deodhar A, Trost D. Inferior Vena Cava (IVC) Filter Placement in Patients Undergoing Orthopedic Surgery: Current Practice. Submitted Dec 2007.
Case Reports:
Kaul M, Silverberg M, DiCarlo EF, Schneider R, Bass AR, Erkan D. Tumor-Induced Osteomalacia. Clin Rheumatol 2007; 26: 1575-9.
Alpert D, Flieder DB, Erkan D, Bass AR. An Unusual Case of Granulomatous Lung Disease. HSS Journal. 2006; 2(2): 191-197.
Bass AR, Schneider R, Sanders A, Glieder D, Nathan CF, Erkan D. Pulmonary Nodules in an Infliximab-Treated Rheumatoid Arthritis Patient. HSS Journal 2007; 3(1): 119-125.
George D, Varley L, Erkan D, Bass AR, Salmon J, Lockshin MD. Primary Antiphospholipid Syndrome Presenting as HELLP Syndrome. HSS Journal 2007; 3(2): 216-221.
Abstracts:
Bass AR, Kopelman, R, McMahon D, Flaster E, D’Agati V, Estes D, Blume RS. High Dose Alternate-Day Steroid (HDADS) Therapy in Lupus Nephritis. Arthritis Rheum. 1990; 33(9): S164.
Berman B, Fields T, Azar N, Pillinger M, Lazaro D, Putterman C, Bass AR, Reyes C, Paget S. The Second Annual New York Rheumatology Objective Structured Clinical Examination (ROSCE): Successful Expansion Demonstrates Feasibility as a Large Scale Rating Tool. Arthritis Rheum 2005; Supplement.
Berman JR, Fields T, Pillinger MH, Lazaro D, Putterman C, Bass AR, Davidson A, Paget S. The Third Annual New York Rheumatology Objective Structured Clinical Examination (ROSCE): Expansion and Validation of Fellow Assessment by Patient and Attending Raters. Arthritis Rheum 2006; 54(9):S782.
Berman JR, Pillinger MH, Bass AR, Fields T, Paget S, Wesinstein, Lazaro D. The Fourth Annual New York City Rheumatology Objective Structured Clinical Examination (NYC ROSCE): Utility for Rating Trainee Professionalism. Arthritis Rheum 2007; 56(9):S539.
Web based publications:
Bass AR. Lyme Disease - Prevention and Treatment. Rheumatology.HSS.edu 2004 June 14.
For more publications, please see the PubMed listing.
Professional Education by Dr. Bass on HSS.edu
- CPC: Churg–Strauss Syndrome with Eosinophilic Myocarditis
- CPC: Catastrophic Antiphospholipid Syndrome Triggered by Sepsis
- CPC: Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease
- CPC: Hepatitis C- and Human Immunodeficiency Virus-Induced Hypersensitivity Vasculitis
- Detection of Pulmonary Embolism in the Postoperative Orthopedic Patient Using Spiral CT Scans
- CPC: Pulmonary Nodules in an Infliximab-Treated Rheumatoid Arthritis Patient
- Lyme Disease of the Nervous System: Tracking the Elusive Spirochete - An Interview with Dr. Bass by Dr. Paget
- CPC: An Unusual Case of Granulomatous Lung Disease
- CPC: Primary Antiphospholipid Syndrome Presenting as HELLP Syndrome
- In RA patients unresponsive to several DMARDs but who are PPD+ although the chest X-ray is negative, how long should INH prophylaxis be maintained before initiating an anti-TNF agent? Is anakinra safe to use in patients with a positive PPD?
- Would a history of optic neuritis be considered a contraindication for TNF-alpha inhibitor therapy? In the few cases of MS-type symptoms in patients on these therapies, have the symptoms reversed when the medications were discontinued?